We are happy to announce regulatory approval for the FlexiLume Dental LED System (www.emci.co/flexilume). Read the full press release here.
James Lucas, EMCI’s Co-Founder, President & CEO, has been invited to become a member of the Coulter Oversight Committee at the University of Missouri (MU).
The Oversight Committee, made up of distinguished representatives from academia, medicine, industry and finance, approves funding and then mentors and monitors funded projects. Funded projects must be explicitly translational and involve collaboration of a bioengineer and a clinician. Projects are managed according to proven industry best practices, with funding tied to milestones set by the project Principal Investigators. Jim was invited onto the Committee in part because of EMCI’s unique focus on taking exciting new medical device technology and translating it into new products that can enhance human health.
Wallace H. Coulter was a visionary entrepreneur with a passion for improving healthcare through medical research and engineering. The Walter H. Coulter Foundation (WHCF) continues the legacy of Mr. Coulter by providing risk capital to innovative initiatives aimed at solving unmet medical needs. The MU/Coulter Translational Partnership (TP) was formed in 2011 to accelerate the translation of biomedical innovations at MU into products and services that improve human health. MU is one of only 16 universities to receive a TP Award from the Wallace H. Coulter Foundation.